⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early.Unlock Stocks

$9 Million Bet On 89bio? 3 Stocks Insiders Are Buying

Published 21/10/2022, 18:45
© Reuters.  $9 Million Bet On 89bio? 3 Stocks Insiders Are Buying
IXIC
-
TCDAQ
-
ETNB
-

Although US stocks closed lower on Thursday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

89bio

  • The Trade: 89bio, Inc. (NASDAQ: ETNB) Director Rajeev Shah acquired a total of 1,172,741 shares an average price of $7.65. To acquire these shares, it cost around $8.97 million.
  • What’s Happening: Raymond James, last month, maintained 89bio with a Strong Buy and raised the price target from $14 to $25.
  • What 89bio Does: 89bio Inc a United States-based clinical-stage biopharmaceutical company focused on the development of therapies for the treatment of liver and cardio-metabolic diseases.

Tricida

  • The Trade: Tricida, Inc. (NASDAQ: TCDA) 10% owner Nimish Shah acquired a total of 351,866 shares at an average price of $10.68. To acquire these shares, it cost around $3.76 million.
  • What’s Happening: Tricida announced a $125 million debt facility with Hercules Capital.
  • What Tricida Does: Tricida Inc is a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis by binding and removing acid from the gastrointestinal, or GI, tract.
Also check this: Why Boston Beer Shares Are Trading Higher? Here Are 52 Stocks Moving In Friday's Mid-Day Session

Coinbase (NASDAQ:COIN) Global

  • The Trade: Coinbase Global , Inc. (NASDAQ: COIN) Director Tobias Lutke bought a total of 5,349 shares at an average price of $72.90. To acquire these shares, it cost around $389.94 thousand.
  • What’s Happening: Google (NASDAQ:GOOGL) recently said it would use Coinbase to start letting customers pay for cloud services with crypto.
  • What Coinbase Global Does: Founded in 2012, Coinbase is the leading cryptocurrency exchange platform in the United States.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.